Skip to content
  • (+61) 2 8203 8741
  • [email protected]
Search
Close
FreshleafAnalytics-logo
  • About Us
    • Our team
  • Services
    • Freshleaf Reports
  • Partners
  • Media
  • News
  • Contact us
Menu
  • About Us
    • Our team
  • Services
    • Freshleaf Reports
  • Partners
  • Media
  • News
  • Contact us
Report H2 2021
Australian Government Legalizes Over-The-Counter CBD
Green Fund
  • September 10, 2020

Green Fund:

Australian Government Legalizes Over-The-Counter CBD

 

Download report H2 2021
PrevPrevious
NextNext

More
articles

2021 has been a bumper year for cannabis and 2022 will be even bigger

October 19, 2021

Australia’s Most Comprehensive Medicinal Cannabis Report: H2 2021

October 18, 2021

Approvals for medicinal cannabis prescriptions hit “record high”

September 9, 2021
FreshleafAnalytics-logo

The team at FreshLeaf Analytics are experts in the medicinal cannabis market in Australia. 

Contact us

  • [email protected]
  • (+61) 2 8203 8741
  • Follow us!
Facebook-f Twitter Linkedin

Get in touch!

© 2022 All rights reserved​, FreshLeaf Analytics

FreshLeaf Analytics H2 2021

The H2 2021 report is FreshLeaf Analytics’ seventh market
report on patients, products and pricing in the Australian
medicinal cannabis market.

Key highlights include:

  • Market growth will exceed expectations in 2021 as active patient numbers surge towards 100,000
  • Revenue from product sales forecast at $230 million at year end
  • Product count continues to climb although the growth rate of new products is slowing
  • Average monthly spend continues its slow downward trend while average daily dose increases
Download Report H2 2021